Institutional investors hold a majority ownership of GRFS through the 57.38% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2016, these large investors purchased a net $2.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 8.5 Million shares of Grifols SA
INSIGHT INVESTMENT MANAGEMENT (G... Bought 4.7 Million shares of Grifols SA
CREDIT SUISSE SECURITIES (USA) L... Bought 3.1 Million shares of Grifols SA